上海金畔生物科技有限公司提供天然产物萜类及其苷类Terpenoids and Glycosides。
Incensole Acetate 纯度: 99.08%
Incensole acetate是卡氏乳香树脂的主要成分,对创伤性和缺血性颅脑损伤中的神经元损伤具有神经保护作用。Incensole acetate 减少了 hOBNSC 中由 Aβ 25-35 触发的细胞凋亡(apoptosis)。
Incensole Acetate Chemical Structure
CAS No. : 34701-53-6
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥1340 | In-stock | |
10 mg | ¥2290 | In-stock | |
25 mg | ¥4570 | In-stock | |
50 mg | ¥6860 | In-stock | |
100 mg | 询价 | ||
200 mg | 询价 |
* Please select Quantity before adding items.
Incensole Acetate 相关产品
•相关化合物库:
- Covalent Screening Library Plus
- Natural Product Library Plus
- Bioactive Compound Library Plus
- Apoptosis Compound Library
- Natural Product Library
- Covalent Screening Library
- Terpenoids Library
- Neuroprotective Compound Library
生物活性 |
Incensole acetate is a main constituent of Boswellia carterii resin, has neuroprotective effects against neuronal damage in traumatic and ischemic head injury. Incensole acetate reduces Aβ25–35-triggered apoptosis in hOBNSCs[1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Incensole acetate (100 μM; pre-treatment 4 hours) significantly ameliorates Aβ 25–35-induced cell death, a 48–52% decrease in cell viability at Aβ25–35 is restored to 85–89% upon pre-treatment with IA[1]. Incensole acetate (5-100 μM) pretreatment reverses increase in the mRNA and protein level of Bax, caspase 8, cyto c and decrease in the mRNA and protein level of Bcl2 induced by Aβ 25–35 in hOBNSCs[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay[1]
|
||||||||||||||||
分子量 |
348.52 |
||||||||||||||||
Formula |
C22H36O3 |
||||||||||||||||
CAS 号 |
34701-53-6 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (286.93 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|